Figure 1.
Plasma concentration–time profile of melphalan after a 1 h infusion of 100 mg m−2 in patients with concomitant aprepitant (n = 10) or placebo (n = 20). Placebo (
); Aprepitant (
)
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.